Panax notoginseng saporins injection vs compound Salvia miltiorrhiza injection in treatment of coronary heart disease with angina pectoris

AIM: To compare the therapeutic effects of panax notoginseng saporins injection and compound Salvia miltiorrhiza injection in treating coronary heart disease with angina pectoris. METHODS: Treatment group of 65 patients (M 44, F 21; age 62 a± s 9 a) received panax notoginseng saporins injection 4 mL in 10% glucose 500 mL, iv, gtt, qd for 20 d. Control group of 50 patients (M 34, F 16; age 60 a±7 a) received compound Salvia miltiorrhiza injection 20 mL in 10% glucose 500 mL, iv, gtt, qd for 20 d. RESULTS: The clinical efficacy of the treatment group was 83%, the ECG efficacy was 82%, and the efficacy of decreasing lipid was 62%; while that of control group was 68%, 62% and 35% respectively. There was significant difference between to the groups P 0.05, in addition, the panax notoginseng saporins injection could improve blood viscosity adverse reaction of the two drugs showed nothing remarkable. CONCLUSION: panax notoginseng saporins injection is superior to compound Salvia miltiorrhiza injection for coronary heart disease with angina pectoris.